Balentine LLC Haleon PLC Transaction History

Balentine LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$8.02 - $8.67 $5,044 - $5,453	-629 Reduced 2.75%	22,274 $189,000
Q4 2023 Feb 09, 2024	SELL	$7.78 - $8.62 $21,721 - $24,067	-2,792 Reduced 10.87%	22,903 $188,000
Q3 2023 Nov 13, 2023	SELL	$7.85 - $8.94 $1,978 - $2,252	-252 Reduced 0.97%	25,695 $214,000
Q2 2023 Aug 14, 2023	SELL	$8.04 - $9.0 $23,195 - $25,965	-2,885 Reduced 10.01%	25,947 $217,000
Q1 2023 May 11, 2023	SELL	$7.57 - $8.37 $86,078 - $95,175	-11,371 Reduced 28.28%	28,832 $234,000
Q4 2022 Jan 31, 2023	BUY	$5.96 - $8.06 $114,724 - $155,146	19,249 Added 91.86%	40,203 $321,000
Q3 2022 Oct 26, 2022	BUY	$5.63 - $7.5 $117,971 - $157,155	20,954 New	20,954 $128,000

638

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $43.4B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.